Published in Biochimie on January 06, 2000
'Conserved hypothetical' proteins: prioritization of targets for experimental study. Nucleic Acids Res (2004) 3.50
Tools for characterization of Escherichia coli genes of unknown function. J Bacteriol (2002) 1.72
The universally conserved prokaryotic GTPases. Microbiol Mol Biol Rev (2011) 1.47
Multiple GTPases participate in the assembly of the large ribosomal subunit in Bacillus subtilis. J Bacteriol (2006) 1.41
Prediction of CsrA-regulating small RNAs in bacteria and their experimental verification in Vibrio fischeri. Nucleic Acids Res (2006) 1.23
Transcriptional analysis of the conserved ftsZ gene cluster in Mycoplasma genitalium and Mycoplasma pneumoniae. J Bacteriol (2005) 1.05
YsxC, an essential protein in Staphylococcus aureus crucial for ribosome assembly/stability. BMC Microbiol (2009) 0.91
Interactions of an essential Bacillus subtilis GTPase, YsxC, with ribosomes. J Bacteriol (2007) 0.88
The highly conserved MraZ protein is a transcriptional regulator in Escherichia coli. J Bacteriol (2014) 0.87
The 70S ribosome modulates the ATPase activity of Escherichia coli YchF. RNA Biol (2012) 0.84
Insertions of mini-Tn10 transposon T-POP in Salmonella enterica sv. typhi. Genetics (2004) 0.82
MraZ from Escherichia coli: cloning, purification, crystallization and preliminary X-ray analysis. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.78
Evidence for lateral gene transfer (LGT) in the evolution of eubacteria-derived small GTPases in plant organelles. Front Plant Sci (2014) 0.75
Potential mechanisms of attenuation for rifampicin-passaged strains of Flavobacterium psychrophilum. BMC Microbiol (2015) 0.75
dnaG gene product, a rifampicin-resistant RNA polymerase, initiates the conversion of a single-stranded coliphage DNA to its duplex replicative form. J Biol Chem (1975) 2.99
Mapping of sequenced genes (700 kbp) in the restriction map of the Escherichia coli chromosome. Mol Microbiol (1990) 2.90
Relationships between the physical and genetic maps of a 470 x 10(3) base-pair region around the terminus of Escherichia coli K12 DNA replication. J Mol Biol (1982) 2.76
Deletion analysis of gene minE which encodes the topological specificity factor of cell division in Escherichia coli. Mol Microbiol (1995) 2.61
Inhibition of replication forks exiting the terminus region of the Escherichia coli chromosome occurs at two loci separated by 5 min. Proc Natl Acad Sci U S A (1987) 2.29
ColE1-type vectors with fully repressible replication. Gene (1991) 2.27
Minicell-forming mutants of Escherichia coli: suppression of both DicB- and MinD-dependent division inhibition by inactivation of the minC gene product. J Bacteriol (1990) 2.10
The RNA primer synthesized by primase to initiate phage G4 DNA replication. J Biol Chem (1978) 2.03
Identification and sequence of gene dicB: translation of the division inhibitor from an in-phase internal start. Nucleic Acids Res (1988) 1.91
Physical map of a 470 x 10(3) base-pair region flanking the terminus of DNA replication in the Escherichia coli K12 genome. J Mol Biol (1982) 1.79
Cell division inhibition gene dicB is regulated by a locus similar to lambdoid bacteriophage immunity loci. Mol Gen Genet (1988) 1.78
Characterization and properties of very large inversions of the E. coli chromosome along the origin-to-terminus axis. Mol Gen Genet (1985) 1.75
Regulation of the expression of the cell-cycle gene ftsZ by DicF antisense RNA. Division does not require a fixed number of FtsZ molecules. Mol Microbiol (1992) 1.71
Replication of phage G4. A novel and simple system for the initiation of deoxyribonucleic acid synthesis. J Biol Chem (1975) 1.69
Signal transduction between a membrane-bound transporter, PtsG, and a soluble transcription factor, Mlc, of Escherichia coli. EMBO J (2000) 1.64
Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst (2001) 1.64
High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene (2000) 1.54
A new dispensable genetic locus of the terminus region involved in control of cell division in Escherichia coli. Mol Gen Genet (1985) 1.53
Health-related quality of life in patients with melanoma expressed as utilities and disability weights. Br J Dermatol (2014) 1.42
New minC mutations suggest different interactions of the same region of division inhibitor MinC with proteins specific for minD and dicB coinhibition pathways. J Bacteriol (1992) 1.38
[Anorectal stenosis caused by suppositories of dextropropoxyphene and paracetamol (Diantalvic)]. Gastroenterol Clin Biol (1986) 1.38
Isolation and mapping of Escherichia coli mutations conferring resistance to division inhibition protein DicB. J Bacteriol (1989) 1.37
Molecular cloning of the region of the terminus of Escherichia coli K-12 DNA replication. J Bacteriol (1983) 1.37
A bioinformatic screen for novel A-I RNA editing sites reveals recoding editing in BC10. Bioinformatics (2005) 1.37
Regulation of Escherichia coli cell division genes ftsA and ftsZ by the two-component system rcsC-rcsB. Mol Microbiol (1999) 1.36
Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function. J Antimicrob Chemother (1983) 1.34
A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet (2001) 1.34
The effect of spermidine on endonuclease inhibition by agarose contaminants. Anal Biochem (1981) 1.33
Genetic evidence that DicF, a second division inhibitor encoded by the Escherichia coli dicB operon, is probably RNA. Mol Microbiol (1989) 1.32
Ofloxacin pharmacokinetics in renal failure. Antimicrob Agents Chemother (1987) 1.27
Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients. J Antimicrob Chemother (1978) 1.21
Escherichia coli cell division inhibitor DicF-RNA of the dicB operon. Evidence for its generation in vivo by transcription termination and by RNase III and RNase E-dependent processing. J Mol Biol (1990) 1.20
Genetic inactivation of topoisomerase I suppresses a defect in initiation of chromosome replication in Escherichia coli. Mol Gen Genet (1984) 1.15
The pharmacokinetics of cefotaxime and its metabolites in subjects with normal and impaired renal function. Rev Infect Dis (1983) 1.15
Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults. Antimicrob Agents Chemother (1988) 1.14
Pharmacokinetics of ceftazidime in normal and uremic subjects. Antimicrob Agents Chemother (1984) 1.13
Optimal dose of lignocaine for preventing pain on injection of propofol. Br J Anaesth (1991) 1.12
oriX: a new replication origin in E. coli. Cell (1984) 1.12
Involvement of FtsZ in coupling of nucleoid separation with septation. Mol Microbiol (1992) 1.11
Pharmacokinetics of norfloxacin in renal failure. J Antimicrob Chemother (1984) 1.10
RNase E processing of essential cell division genes mRNA in Escherichia coli. Nucleic Acids Res (1996) 1.10
Identification of a new inhibitor of essential division gene ftsZ as the kil gene of defective prophage Rac. J Bacteriol (1996) 1.07
Control of cell division in Escherichia coli. DNA sequence of dicA and of a second gene complementing mutation dicA1, dicC. Nucleic Acids Res (1986) 1.04
Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo. J Virol (2000) 1.01
Pharmacokinetics of moxalactam in subjects with normal and impaired renal function. Antimicrob Agents Chemother (1981) 0.99
Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis. Clin Pharmacokinet (1990) 0.99
Division inhibition gene dicF of Escherichia coli reveals a widespread group of prophage sequences in bacterial genomes. J Bacteriol (1994) 0.98
Computer-assisted access to the kidney. Int J Med Robot (2005) 0.96
Pharmacokinetics of azlocillin in subjects with normal and impaired renal function. Antimicrob Agents Chemother (1980) 0.96
Pharmacokinetics of cefotaxime in subjects with normal and impaired renal function. J Antimicrob Chemother (1980) 0.96
The cytogenetic dosimetry of recent accidental overexposure. Cell Mol Biol (Noisy-le-grand) (2001) 0.96
Comparative pharmacokinetics of lividomycin, amikacin and sisomicin in normal subjects and in uraemic patients. J Antimicrob Chemother (1976) 0.96
Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency. Chemotherapy (1979) 0.94
Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms. Cancer (1980) 0.94
Pharmacokinetics of aminoglycosides in subjects with normal and impaired renal function. Antibiot Chemother (1971) (1978) 0.93
Involvement of both DNA polymerases alpha and gamma in the replication of adenovirus deoxyribonucleic acid in vitro. Virology (1980) 0.92
An Escherichia coli gene (yaeO) suppresses temperature-sensitive mutations in essential genes by modulating Rho-dependent transcription termination. Mol Microbiol (1998) 0.92
RBC membrane adenosine triphosphatase activities in patients with major affective disorders. Arch Gen Psychiatry (1983) 0.92
Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis. J Antimicrob Chemother (1984) 0.92
Effect of gravity on human spontaneous 10-Hz electroencephalographic oscillations during the arrest reaction. Brain Res (2006) 0.91
Escherichia coli RNA degradosome. Methods Enzymol (2001) 0.91
The spacing of Escherichia coli DNA gyrase sites cleaved in vivo by treatment with oxolinic acid and sodium dodecyl sulfate. Biochimie (1985) 0.91
Pharmacokinetics of dibekacin in normal subjects and in patients with renal failure. J Antimicrob Chemother (1980) 0.90
The pharmacokinetics of ofloxacin in healthy adult male volunteers. Eur J Clin Pharmacol (1987) 0.89
Pharmacokinetics of netilmicin in the presence of normal or impaired renal function. Antimicrob Agents Chemother (1978) 0.89
Origin of Escherichia coli K-12 Hfr B7. J Bacteriol (1983) 0.88
Cefoxitin concentrations in the cerebrospinal fluids of patients with meningitis. Antimicrob Agents Chemother (1980) 0.88
Relationship between renal function and disposition of oral cefixime. Eur J Clin Pharmacol (1991) 0.87
Pharmacokinetics of habekacin in patients with renal insufficiency. Antimicrob Agents Chemother (1987) 0.87
Uptake of platinum compounds in human tumors. In vitro study. Bull Cancer (1986) 0.86
Structure-based mechanism of ligand binding for periplasmic solute-binding protein of the Bug family. J Mol Biol (2007) 0.86
The min locus, which confers topological specificity to cell division, is not involved in its coupling with nucleoid separation. J Bacteriol (1994) 0.85
Cell cycle control: prokaryotic solutions to eukaryotic problems? J Theor Biol (1994) 0.85
Recovery of nanogram quantities of DNA from plasma and quantitative measurement using labeling by nick translation. Anal Biochem (1986) 0.85
OriX: a new origin of replication in E. coli. Correction. Cell (1984) 0.84
Molecular mechanisms of invasion by cancer cells, leukocytes and microorganisms. Microbes Infect (2000) 0.84
DNA methylases of Escherichia coli K12. Evidence for changes in their state of association following purification. Eur J Biochem (1972) 0.84
Formation of asteroid pairs by rotational fission. Nature (2010) 0.84
Pharmacokinetics of quinolones in renal insufficiency. J Antimicrob Chemother (1990) 0.84
Sigma S-dependent overexpression of ftsZ in an Escherichia coli K-12 rpoB mutant that is resistant to the division inhibitors DicB and DicF RNA. Mol Gen Genet (1995) 0.83
Inaccuracy of tidal volume delivered by home mechanical ventilators. Eur Respir J (2000) 0.83
MinCD-independent inhibition of cell division by a protein that fuses MalE to the topological specificity factor MinE. J Bacteriol (1997) 0.83
Escherichia coli dicB operon includes a truncated IS2 element. Nucleic Acids Res (1988) 0.83
Pharmacokinetics of cefoxitin in normal subjects and in patients with renal insufficiency. Rev Infect Dis (1989) 0.82
Pharmacokinetics of aztreonam in patients with chronic renal failure. Clin Pharmacokinet (1985) 0.82
Standardization of an enzymometric assay for apolipoprotein A-I by using mixtures of monoclonal antibodies). J Clin Chem Clin Biochem (1987) 0.82
Comparison of the effects of purified human alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor on NK cytotoxicity: only alpha 1-proteinase inhibitor inhibits natural killing. Clin Chim Acta (1990) 0.81
Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. I. Chromosome aberrations induced in vivo. Mutat Res (1990) 0.81
Pharmacokinetics of azlocillin in healthy subjects. Scand J Infect Dis Suppl (1981) 0.81
Minor hemisphere syndrome following left hemispheric lesion in a right handed patient. J Neurol Neurosurg Psychiatry (1991) 0.81
Real-time reverse-transcription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion. Int J Biol Markers (2008) 0.80
Mimicking lipid-binding-induced conformational changes in the human apolipoprotein E N-terminal receptor binding domain effects of low pH and propanol. Eur J Biochem (1999) 0.79
Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. II. Alteration of DNA repair and chromosome radiosensitivity. Mutat Res (1990) 0.78
Adaptive changes of rhythmic EEG oscillations in space implications for brain-machine interface applications. Int Rev Neurobiol (2009) 0.78
[Interhemispheric disconnection syndrome with diagonistic dyspraxia in the course of Marchiafava-Bignami disease]. Rev Neurol (Paris) (1978) 0.78
Caffeine decreases glial cell number and increases hyaluronan secretion in newborn rat brain cultures. Pediatr Res (1993) 0.77
Effects of dietary maritime pine (Pinus pinaster)-seed oil on high-density lipoprotein levels and in vitro cholesterol efflux in mice expressing human apolipoprotein A-I. Br J Nutr (2000) 0.77
Inhibition of lecithin cholesterol acyltransferase by phosphatidylcholine hydroperoxides. FEBS Lett (1999) 0.77
BEE95: a novel sequence family related to IRU/ERIC dispersed enterobacterial intergenic elements. Mol Microbiol (1995) 0.77
Cellular and molecular mechanisms of metastasis as applied to carcinomatous meningitis. J Neurooncol (1998) 0.77